Goofy posted earlier on some recent studies for geno 2's and 3's, so I thought I'd recopy his post here. If he sees this he might post the link in a more elegant way but for now here it is to copy and paste in your browser window: http://tinyurl.com/juna9
Free registration required but well worth it.
------------------------------------------
From the paper:
Taken together, these 4 studies indicate that shorter duration of therapy may be effective for patients with genotype 2 or 3 and RVR. However, in applying these findings to the clinical setting, physicians should take into account that patients in these protocols were treated with weight-based ribavirin (800-1400 mg/day or 1000-1200 mg/day) rather than the standard fixed-dose ribavirin (800 mg/day) approved by the US Food and Drug Administration (FDA) for the treatment of patients with HCV genotypes 2 or 3.
Personally, I like the idea of starting with higher riba knowing you can always cut back if it's not tollerated. If you maintain the high riba, you might consider the 16 week stopping point if you're having a difficult treatment or just plain want to. It's a reasonable course to take.
Good luck!
I'm in the kennel with you.
Geno3a
tx'd 24 weeks peg-intron and 800 riba
early cirrhosis
und at 12 and 24, relapsed at 5 month (1st post tx pcr)
required neup, ambien, not procrit
platelets averaged in the 60's
Next time (advised by a liverhead)
1200 riba (weigh-based for 180 lbs) probably pre-dose a week
48 weeks
not sure which peg yet
neup at 500, procrit at 11, platelets can go to 30